Comparison of two region of interest definition methods for metabolic response evaluation with [18F]FDG-PET

被引:0
|
作者
Vriens, D. [1 ]
De Geus-Oei, L. F. [1 ]
Van Laarhoven, H. W. M. [2 ]
Van der Heijden, H. F. M. [3 ]
Krabbe, P. F. M. [4 ]
Visser, E. P. [1 ]
Oyen, W. J. G. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6500 HB Nijmegen, Netherlands
关键词
Colorectal carcinoma; Non-small cell lung carcinoma; F-18]FDG; Positron emission tomography; Chemotherapy; Drug monitoring; Survival; Neoplasms; therapy; POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; WHOLE-BODY PET; F-18-FDG PET; ROI DEFINITION; COMPUTED-TOMOGRAPHY; UPTAKE VALUES; FDG-PET; CHEMOTHERAPY; PREDICTION;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim. In therapy response monitoring by [F-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET), different tumor delineations are used, resulting in different values for change in glucose metabolic rate (Delta MRglu). We propose a technique to compare metabolic rates in a region of interest (ROI) based on fixed volumes rather than on fixed thresholds. This method involves change in lesion size. Methods. In 49 patients with colorectal carcinoma (CRC) and 50 patients with non-small cell lung carcinoma (NSCLC) scheduled for chemotherapy, FDG-PET was performed at baseline and during chemotherapy. A ROIfixed thresholds was determined by using a 50% threshold on both baseline and follow-up FDG-PET. A ROIfixed (volumes) was determined by using a 50% threshold, determined on the series with the largest tumor volume. This ROIfixed volumes is used on consecutive scans. Predictive effects of both methods were investigated by survival analysis for overall and progression free survival. Results. In CRC, only ROIfixed volumes based Delta MRglu showed significant predictive ability. In NSCLC, both techniques showed significant predictive ability. During multivariate analysis, ROIfixed volumes determined Delta MRglu was an independent predictor for both overall and progression free survival in NSCLC whereas ROIfixed thresholds determined MRglu was not. After dichotomization at the median Delta MRglu, median survival ratio was higher in ROIfixed volumes than ROIfixed thresholds for CRC (overall survival: 1.78 vs 1.25, progression free survival: 1.57 vs 1.21) and NSCLC (overall survival: 2.01 vs 2.01, progression free survival: 2.93 vs 2.13). Conclusion. ROIfixed volumes based Delta MRglu shows better correlation with survivarethan Delta MRglu determined from a ROIfixed thresholds
引用
收藏
页码:677 / 688
页数:12
相关论文
共 50 条
  • [1] [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer
    Been, Lukas B.
    Hoekstra, Harald J.
    Suurmeijer, Albert J. H.
    Jager, Pieter L.
    van der Laan, Bernard F. A. M.
    Elsinga, Philip H.
    ORAL ONCOLOGY, 2009, 45 (12) : E211 - E215
  • [2] [18F]-FDG-PET in therapy response of esophageal cancer
    Wieder, H. A.
    Herrmann, K.
    Ott, K.
    Krause, B. J.
    RADIOLOGE, 2007, 47 (02): : 110 - 114
  • [3] The role of [18F]FDG-PET in the evaluation of follicular lymphoma
    Zanoni, Lucia
    Lopci, Egesta
    Stefoni, Vittorio
    Fonti, Cristina
    Nanni, Cristina
    Castellucci, Paolo
    Montini, Gian Carlo
    Maffione, Anna Margherita
    Zinzani, Pierluigi
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [4] Evaluation of renal glucose uptake with [18F]FDG-PET: Methodological advancements and metabolic outcomes
    Rebelos, Eleni
    Mari, Andrea
    Oikonen, Vesa
    Iida, Hidehiro
    Nuutila, Pirjo
    Ferrannini, Ele
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 141
  • [5] [18F]-FDG-PET/CT Early Response to Nivolumab in NSCLC
    Bellevre, Dimitri
    Petyt, Gegory
    Collet, Guillaume
    Hossein-Foucher, Claude
    Baldacci, Simon
    Baranzelli, Anne
    Semah, Franck
    Cortot, Alexis
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S402 - S402
  • [6] [18F]-FDG-PET/CT early response to nivolumab in NSCLC
    Bellevre, Dimitri
    Petyt, Gregory
    Collet, Guillaume
    Hossein-Foucher, Claude
    Semah, Franck
    Cortot, Alexis
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [7] Ensemble Methods with [18F]FDG-PET/CT Radiomics in Breast Cancer Response Prediction
    Dholey, Moumita
    Santosham, Ritesh J. M.
    Ray, Soumendranath
    Das, Jayanta
    Chatterjee, Sanjoy
    Ahmed, Rosina
    Mukherjee, Jayanta
    PATTERN RECOGNITION AND MACHINE INTELLIGENCE, PREMI 2023, 2023, 14301 : 369 - 379
  • [8] [18F]FDG-PET CT for the evaluation of native valve endocarditis
    Abikhzer, Gad
    Martineau, Patrick
    Gregoire, Jean
    Finnerty, Vincent
    Harel, Francois
    Pelletier-Galarneau, Matthieu
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (01) : 158 - 165
  • [9] [18F]FDG-PET CT for the evaluation of native valve endocarditis
    Gad Abikhzer
    Patrick Martineau
    Jean Grégoire
    Vincent Finnerty
    Francois Harel
    Matthieu Pelletier-Galarneau
    Journal of Nuclear Cardiology, 2022, 29 : 158 - 165
  • [10] Whole-Body [18F]FDG-PET/MRI vs. [18F]FDG-PET/CT in Malignant Melanoma
    Dominik Berzaczy
    Barbara Fueger
    Christoph Hoeller
    Alexander R. Haug
    Anton Staudenherz
    Gundula Berzaczy
    Michael Weber
    Marius E. Mayerhoefer
    Molecular Imaging and Biology, 2020, 22 : 739 - 744